Anti-VEGF for neovascular ARMD: visual improvement as the goal of therapy?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17895411.
- Also identified by PMC identifier 2001031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There has been dramatic progress in anti‐VEGF therapy, but future guidelines are needed
Medical subject headings
- Angiogenesis Inhibitors
- Macular Degeneration
- Vascular Endothelial Growth Factor A